about
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF ...
Read More
2.35
0.08
(3.52%)
267.0K
XNAS Volume
XNAS 10 Nov, 2025 10:58 AM (EST)
Board Meeting
The next board meeting for Erasca Inc is on 19 Nov 2025 for the purpose of Jefferies Global Healthcare Conference
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Erasca Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..